DISORDER
MECHANISM
FEATURES
CLUE
Imbalance between acid and mucosal defense (mucus, HCO₃⁻, blood flow, prostaglandins)
Erosions (mucosa only); dyspepsia, hematemesis, melena
NSAIDs (↓ PGE₂), alcohol, chemo, uremia
Severe burns → hypovolemia → mucosal ischemia
Acute stress ulcers in stomach/duodenum
"Burned by the Curling iron"
Brain injury → ↑ vagal tone → ↑ ACh → ↑ acid
Stress ulcers after head trauma, tumor, surgery
"Always Cushion the brain"
Stress-related mucosal disease
Shock, sepsis, mechanical ventilation, coagulopathy → ischemia
Multiple superficial erosions, GI bleeding in ICU
PPI prophylaxis in high-risk ICU patients
H pylori gastritis
most common chronic
Gram⁻ curved rod, urease → NH₃ buffers acid and injures mucosa; flagella, CagA, VacA
Starts in antrum; lymphoid follicles, neutrophils; may spread (pangastritis)
Peptic ulcers, intestinal-type adenocarcinoma, MALT lymphoma
CD4 T-cell (type IV) attack on parietal cells; anti-parietal cell (H⁺/K⁺-ATPase) and anti-intrinsic factor antibodies
Body/fundus atrophy; achlorhydria; ↑↑ gastrin; G-cell hyperplasia (antrum spared)
Pernicious anemia; other autoimmune disease (thyroid, T1DM, vitiligo)
Chemical (reactive) gastropathy
Bile reflux (post-gastrectomy), NSAIDs, alcohol
Foveolar hyperplasia, few inflammatory cells
Injury without much inflammation
↑ TGF-α / EGFR signaling → foveolar (mucous) cell hyperplasia
Giant rugal folds in body/fundus; parietal cell atrophy; protein-losing → hypoalbuminemia, edema
Precancerous; can mimic Zollinger-Ellison on imaging
Chronic H pylori antigen drives B cells; t(11;18) resists eradication therapy
Marginal zone B-cell lymphoma
Early disease regresses after H pylori eradication
Gastric carcinoid (type 1)
Autoimmune gastritis → chronic hypergastrinemia → ECL cell hyperplasia
Small, multiple, usually indolent neuroendocrine tumors
Gastrin is trophic to ECL cells